Long-Term Progression-Free Survival of Third-Line Apatinib in Lung Squamous Cell Carcinoma
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s154567
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Informa UK Limited